Development and function of TH17 cells in health and disease

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 5, 2009, Pages 1004-1011

  Louten, Jennifer ^a   Boniface, Katia ^a   de Waal Malefyt, Rene ^a  

^a Schering Plough Biopharma ^*  (United States)

Author keywords

allergy; cytokines; IL 17; IL 22; IL 23; TH cell; TH17 cell

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; CYTOKINE;

ALLERGY; ANIMAL CELL; ARTICLE; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL STRAIN NK22; CELL STRAIN ROR GAMMA T NK P46; CONTACT DERMATITIS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TH17 CELL; TRANSCRIPTION REGULATION; ANIMAL; AUTOIMMUNITY; HELPER CELL; HYPERSENSITIVITY; IMMUNOLOGY; INFECTION; METABOLISM; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINES; HUMANS; HYPERSENSITIVITY; INFECTION; INTERLEUKIN-17; NATURAL KILLER T-CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 65349119355     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.04.003     Document Type: Article

References (94)

1. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 (1986) 2348-2357
2. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25 (2007) 221-242
3. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
4. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198 (2003) 1951-1957
5. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177 (2006) 566-573
6. Nakae S., Nambu A., Sudo K., and Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171 (2003) 6173-6177
7. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278 (2003) 1910-1914
8. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
9. Ivanov II, McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
10. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282 (2007) 9358-9363
11. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178 (2007) 4901-4907
12. Harris T.J., Grosso J.F., Yen H.R., Xin H., Kortylewski M., Albesiano E., et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 179 (2007) 4313-4317
13. Manel N., Unutmaz D., and Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9 (2008) 641-649
14. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453 (2008) 106-109
15. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
16. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
17. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
18. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
19. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
20. Zhou L., Ivanov II, Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (2007) 967-974
21. Sonderegger I., Kisielow J., Meier R., King C., and Kopf M. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol 38 (2008) 1833-1838
22. Coquet J.M., Chakravarti S., Smyth M.J., and Godfrey D.I. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol 180 (2008) 7097-7101
23. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8 (2007) 1390-1397
24. McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10 (2009) 314-324
25. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204 (2007) 1849-1861
26. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8 (2007) 639-646
27. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
28. Cosmi L., De Palma R., Santarlasci V., Maggi L., Capone M., Frosali F., et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 205 (2008) 1903-1916
29. Kleinschek M.A., Boniface K., Sadekova S., Grein J., Murphy E.E., Turner S.P., et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 206 (2009) 525-534
30. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., and Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8 (2007) 942-949
31. van Beelen A.J., Zelinkova Z., Taanman-Kueter E.W., Muller F.J., Hommes D.W., Zaat S.A., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27 (2007) 660-669
32. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454 (2008) 350-352
33. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupe P., Barillot E., et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9 (2008) 650-657
34. Chen Z., Tato C.M., Muul L., Laurence A., and O'Shea J.J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56 (2007) 2936-2946
35. Santarlasci V., Maggi L., Capone M., Frosali F., Querci V., De Palma R., et al. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 39 (2009) 207-215
36. Burgler S., Ouaked N., Bassin C., Basinski T.M., Mantel P.Y., Siegmund K., et al. Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 123 (2009) 588-595 e1-7
37. Chizzolini C., Chicheportiche R., Alvarez M., de Rham C., Roux-Lombard P., Ferrari-Lacraz S., et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112 (2008) 3696-3703
38. Boniface K., Bak-Jensen K.S., Li Y., Blumenschein W.M., McGeachy M.J., McClanahan T.K., et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic-AMP and EP2/EP4 receptor signaling. J Exp Med 206 (2009) 535-548
39. Sheibanie A.F., Tadmori I., Jing H., Vassiliou E., and Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 18 (2004) 1318-1320
40. Sheibanie A.F., Yen J.H., Khayrullina T., Emig F., Zhang M., Tuma R., et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis. J Immunol 178 (2007) 8138-8147
41. Sheibanie A.F., Khayrullina T., Safadi F.F., and Ganea D. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis Rheum 56 (2007) 2608-2619
42. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194 (2001) 519-527
43. Huang W., Na L., Fidel P.L., and Schwarzenberger P. Requirement of interleukin-17A for systemic anti- Candida albicans host defense in mice. J Infect Dis 190 (2004) 624-631
44. Eyerich K., Foerster S., Rombold S., Seidl H.P., Behrendt H., Hofmann H., et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128 (2008) 2640-2645
45. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14 (2008) 275-281
46. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14 (2008) 282-289
47. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30 (2009) 108-119
48. Brenchley J.M., Paiardini M., Knox K.S., Asher A.I., Cervasi B., Asher T.E., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112 (2008) 2826-2835
49. Romagnani S. Human Th17 cells. Arthritis Res Ther 10 (2008) 206
50. Boniface K., Blom B., Liu Y.J., and de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev 226 (2008) 132-146
51. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8 (2008) 458-466
52. Di Cesare A., Di Meglio P., and Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol (2009) [Epub ahead of print]
53. Pene J., Chevalier S., Preisser L., Venereau E., Guilleux M.H., Ghannam S., et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180 (2008) 7423-7430
54. Albanesi C., Cavani A., and Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 162 (1999) 494-502
55. Albanesi C., Scarponi C., Cavani A., Federici M., Nasorri F., and Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol 115 (2000) 81-87
56. Larsen J.M., Bonefeld C.M., Poulsen S.S., Geisler C., and Skov L. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 123 (2009) 486-492
57. Koga C., Kabashima K., Shiraishi N., Kobayashi M., and Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128 (2008) 2625-2630
58. Cheung P.F., Wong C.K., and Lam C.W. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 180 (2008) 5625-5635
59. Di Cesare A., Di Meglio P., and Nestle F.O. A role for Th17 cells in the immunopathogenesis of atopic dermatitis?. J Invest Dermatol 128 (2008) 2569-2571
60. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162 (1999) 2347-2352
61. Oboki K., Ohno T., Saito H., and Nakae S. Th17 and allergy. Allergol Int 57 (2008) 121-134
62. Henness S., Johnson C.K., Ge Q., Armour C.L., Hughes J.M., and Ammit A.J. IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol 114 (2004) 958-964
63. Kawaguchi M., Kokubu F., Kuga H., Matsukura S., Hoshino H., Ieki K., et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 108 (2001) 804-809
64. Chakir J., Shannon J., Molet S., Fukakusa M., Elias J., Laviolette M., et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111 (2003) 1293-1298
65. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108 (2001) 430-438
66. Schnyder-Candrian S., Togbe D., Couillin I., Mercier I., Brombacher F., Quesniaux V., et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203 (2006) 2715-2725
67. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 (2002) 375-387
68. He R., Oyoshi M.K., Jin H., and Geha R.S. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci U S A 104 (2007) 15817-15822
69. Hellings P.W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L., et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 28 (2003) 42-50
70. Fujiwara M., Hirose K., Kagami S., Takatori H., Wakashin H., Tamachi T., et al. T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J Allergy Clin Immunol 119 (2007) 662-670
71. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9 (2008) 166-175
72. Rickel E.A., Siegel L.A., Yoon B.R., Rottman J.B., Kugler D.G., Swart D.A., et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 181 (2008) 4299-4310
73. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181 (2008) 6117-6124
74. Wakashin H., Hirose K., Maezawa Y., Kagami S., Suto A., Watanabe N., et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178 (2008) 1023-1032
75. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30 (2009) 92-107
76. Martinez G.J., Nurieva R.I., Yang X.O., and Dong C. Regulation and function of proinflammatory TH17 cells. Ann N Y Acad Sci 1143 (2008) 188-211
77. Tanaka J., Watanabe N., Kido M., Saga K., Akamatsu T., Nishio A., et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 39 (2009) 89-100
78. McKinley L., Alcorn J.F., Peterson A., Dupont R.B., Kapadia S., Logar A., et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 181 (2008) 4089-4097
79. Paulson M.L., Freeman A.F., and Holland S.M. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol 8 (2008) 527-533
80. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205 (2008) 1551-1557
81. de Beaucoudrey L., Puel A., Filipe-Santos O., Cobat A., Ghandil P., Chrabieh M., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 205 (2008) 1543-1550
82. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (2008) 773-776
83. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., and Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22 (2005) 285-294
84. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204 (2007) 995-1001
85. Yoshiga Y., Goto D., Segawa S., Ohnishi Y., Matsumoto I., Ito S., et al. Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int J Mol Med 22 (2008) 369-374
86. Goto M., Murakawa M., Kadoshima-Yamaoka K., Tanaka Y., Nagahira K., Fukuda Y., et al. Murine NKT cells produce Th17 cytokine interleukin-22. Cell Immunol 254 (2009) 81-84
87. Luci C., Reynders A., Ivanov II, Cognet C., Chiche L., Chasson L., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 10 (2009) 75-82
88. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10 (2009) 83-91
89. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009) 722-725
90. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008) 958-970
91. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., and Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29 (2008) 947-957
92. Ivanov II, Diehl G.E., and Littman D.R. Lymphoid tissue inducer cells in intestinal immunity. Curr Top Microbiol Immunol 308 (2006) 59-82
93. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10 (2009) 66-74
94. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov II, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206 (2009) 35-41